Vertex Pharmaceuticals Inc
VRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000875320
In the last 90 days, Vertex Pharmaceuticals Inc insiders filed 0 open-market purchases and 4 sales; 1,763 institutions reported holding it in 13F filings for Q2 2026, worth $119.7B in total; no superinvestor holds it.
Holders of 5% or more of VRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vertex Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Capital World Investors | 13G/A | 11.20%28.7M shares | – | Feb 13, 20251 filing | Feb 13, 2025 | SEC |
| Capital Research Global Investors | 13G | 5.70%14.5M shares | New | May 13, 20251 filing | May 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Vertex Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20261:54 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| May 13, 202511:32 AM ET | Capital Research Global Investors | 13G | 5.70%14.5M shares | New | Mar 31, 2025 | SEC |
| Feb 13, 20254:53 PM ET | Capital World Investors | 13G/A | 11.20%28.7M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20259:34 AM ET | FMR LLCand 1 other | 13G/A | 3.60%9.22M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vertex Pharmaceuticals Inc shares.
No Form 144 notices for Vertex Pharmaceuticals Inc are on file.